Skip to main content

Advertisement

Log in

Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis

  • Epidemiology of RMD
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Patients with rheumatoid arthritis (RA) have a high risk for comorbid conditions which increase mortality, hospital admissions, costs of care and inability. To evaluate the prevalence of comorbidities in Mexican mestizo patients with RA and determine the associated risk factors. Cross-sectional study in which RA patients admitted to our outpatient clinic were consecutively enrolled. We collected data regarding demographics, disease characteristics and comorbidities at the time of the patient’s visit to the clinic. We analyzed 225 patients. Their mean age was 55.7 ± 8.3 years; disease duration, 9.5 (3.8–15.5) years; female gender, 93.8%; Disease Activity Score using 28 joints-C-reactive protein, 3 (2–4); methotrexate use, 84.9%; use of any other conventional disease modifying anti-rheumatic drug, 65.7%; use of biological agents, 8%. The most frequently associated diseases were: hypertension, 29.8%; dyslipidemia, 27.1%; osteoporosis, 19.1%; diabetes, 12.4%; hypothyroidism, 6.2%; solid malignancies 4.4%. Risk factors were also evaluated, the most prevalent was overweight in 101 (44.9%) of our patients. A total of 71 (31.6%) had obesity. We also detected high blood pressure in 12.4%, hyperglycemia in 27.1% and hyperlipidemia in 49.8%. Due to the high frequency of comorbidities among RA patients, it is important to follow existing recommendations for their timely detection and management. Cardiovascular diseases must be evaluated with priority. The initial evaluation should include a thorough examination to prevent the deleterious effect of comorbidities in RA.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. You S, Cho CS, Lee I, Hood L, Hwang D, Kim WU (2012) A systems approach to rheumatoid arthritis. PLoS One 7(12):e51508. doi:10.1371/journal.pone.0051508

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Gibofsky A (2012) Overview of epidemiology, pathophysiology, and diagnosis of rheumatoid arthritis. Am J Manag Care 18(13 Suppl):S295–S302

    PubMed  Google Scholar 

  3. Myasoedova E, Davis JM 3rd, Crowson CS, Gabriel SE (2010) Epidemiology of rheumatoid arthritis: rheumatoid arthritis and mortality. Curr Rheumatol Rep 12(5):379–385. doi:10.1007/s11926-010-0117-y

    Article  PubMed  Google Scholar 

  4. Pelaez-Ballestas I, Sanin LH, Moreno-Montoya J, Alvarez-Nemegyei J, Burgos-Vargas R, Garza-Elizondo M, Rodriguez-Amado J, Goycochea-Robles MV, Madariaga M, Zamudio J, Santana N, Cardiel MH (2011) Epidemiology of the rheumatic diseases in Mexico. A study of 5 regions based on the COPCORD methodology. J Rheumatol Suppl 86:3–8. doi:10.3899/jrheum.100951

    Article  PubMed  Google Scholar 

  5. Wolfe F, Michaud K (2008) The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis: a cohort and nested case-control analysis. Arthritis Rheum 58(9):2612–2621. doi:10.1002/art.23811

    Article  PubMed  Google Scholar 

  6. Michaud K, Wolfe F (2007) Comorbidities in rheumatoid arthritis. Best Pract Res Clin Rheumatol 21(5):885–906. doi:10.1016/j.berh.2007.06.002

    Article  PubMed  Google Scholar 

  7. Gabriel SE, Michaud K (2009) Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther 11(3):229. doi:10.1186/ar2669

    Article  PubMed  PubMed Central  Google Scholar 

  8. Chandrashekara S, India CRaICB, Shobha V, India SJsMCHB, Dharmanand BG, India SHB, Jois R, India KDCB, Kumar S, India CAHB, Mahendranath KM, India SHCB, Haridas V, India ASCH, Prasad S, India VHPLM, Singh Y, India MHMK, Daware MA, India NHCMK, Swamy A, India ACMK, Subramanian R, India JMCMK, Somashekar SA, India BRCB, Shanthappa AM, India ARCT, Anupama KR, India CRaICB (2017) Factors influencing remission in rheumatoid arthritis patients: results from Karnataka rheumatoid arthritis comorbidity (KRAC) study. Int J Rheum Dis doi:10.1111/1756-185X.12908

  9. Baillet A, Gossec L, Carmona L, Wit M, van Eijk-Hustings Y, Bertheussen H, Alison K, Toft M, Kouloumas M, Ferreira RJ, Oliver S, Rubbert-Roth A, van Assen S, Dixon WG, Finckh A, Zink A, Kremer J, Kvien TK, Nurmohamed M, van der Heijde D, Dougados M (2016) Points to consider for reporting, screening for and preventing selected comorbidities in chronic inflammatory rheumatic diseases in daily practice: a EULAR initiative. Ann Rheum Dis 75(6):965–973. doi:10.1136/annrheumdis-2016-209233

    Article  PubMed  Google Scholar 

  10. Hernández-Ávila M, Rivera-Dommarco J, Shamah-Levy L, Gómez-Acosta LM, Gaona-Pineda EB (2016) Encuesta Nacional de Salud y Nutrición 2016: Resultados Nacionales. Instituto Nacional de Salud Pública 2016, Cuernavaca, México

  11. Dougados M, Soubrier M, Antunez A, Balint P, Balsa A, Buch MH, Casado G, Detert J, El-Zorkany B, Emery P, Hajjaj-Hassouni N, Harigai M, Luo SF, Kurucz R, Maciel G, Mola EM, Montecucco CM, McInnes I, Radner H, Smolen JS, Song YW, Vonkeman HE, Winthrop K, Kay J (2014) Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA). Ann Rheum Dis 73(1):62–68. doi:10.1136/annrheumdis-2013-204223

    Article  PubMed  Google Scholar 

  12. Sarmiento-Monroy JC, Amaya-Amaya J, Espinosa-Serna JS, Herrera-Diaz C, Anaya JM, Rojas-Villarraga A (2012) Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America. Arthritis 2012:371909. doi:10.1155/2012/371909

    Article  PubMed  PubMed Central  Google Scholar 

  13. Solomon DH, Love TJ, Canning C, Schneeweiss S (2010) Risk of diabetes among patients with rheumatoid arthritis, psoriatic arthritis and psoriasis. Ann Rheum Dis 69(12):2114–2117. doi:10.1136/ard.2009.125476

    Article  PubMed  PubMed Central  Google Scholar 

  14. Gremese E, Ferraccioli G (2011) The metabolic syndrome: the crossroads between rheumatoid arthritis and cardiovascular risk. Autoimmun Rev 10(10):582–589. doi:10.1016/j.autrev.2011.04.018

    Article  CAS  PubMed  Google Scholar 

  15. Avouac J, Amrouche F, Meune C, Rey G, Kahan A, Allanore Y (2016) Mortality profile of patients with rheumatoid arthritis in France and its change in 10 years. Semin Arthritis Rheum. doi:10.1016/j.semarthrit.2016.10.007

    Google Scholar 

  16. Solomon DH, Curhan GC, Rimm EB, Cannuscio CC, Karlson EW (2004) Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 50(11):3444–3449. doi:10.1002/art.20636

    Article  PubMed  Google Scholar 

  17. Garip Y, Eser F, Bodur H (2016) Comorbidities in Turkish patients with rheumatoid arthritis: association with the health-related quality of life in terms of disease activity, functional and radiological status, severity of pain, and social and emotional functioning. Acta Reumatol Port 41(4):344–349

    PubMed  Google Scholar 

  18. Carlos F, Clark P, Galindo-Suarez RM, Chico-Barba LG (2013) Health care costs of osteopenia, osteoporosis, and fragility fractures in Mexico. Arch Osteoporos 8:125. doi:10.1007/s11657-013-0125-4

    Article  PubMed  Google Scholar 

  19. Widdifield J, Ivers NM, Bernatsky S, Jaakkimainen RL, Bombardier C, Thorne JC, Ahluwalia V, Paterson JM, Young J, Wing L, Tu K (2016) Primary care screening and management of comorbidity in rheumatoid arthritis in Ontario, Canada. Arthritis Care Res (Hoboken). doi:10.1002/acr.23178

    Google Scholar 

  20. Caplan A, Fett N, Rosenbach M, Werth VP, Micheletti RG (2017) Prevention and management of glucocorticoid-induced side effects: a comprehensive review: a review of glucocorticoid pharmacology and bone health. J Am Acad Dermatol 76(1):1–9. doi:10.1016/j.jaad.2016.01.062

    Article  PubMed  Google Scholar 

  21. Firestein G, Gabriel S, McInnes I, O’Dell J (2017) Kelley and Firestein’s textbook of rheumatology, 10th edn, Elsevier, Philadeplphia, PA, USA, p 1120

    Google Scholar 

  22. Pelaez I, Infante C, Quintana R (2015) Help-seeking trajectory in patients with rheumatoid arthritis. Clin Rheumatol 34:17–28. doi:10.1007/s10067-015-3013-z

    Article  PubMed Central  Google Scholar 

  23. Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Sodergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT (2016) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. doi:10.1136/annrheumdis-2016-209775

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Dionicio A. Galarza-Delgado.

Ethics declarations

Conflict of interest

None of the authors declare any conflict of interest.

Ethical statement

All procedures performed in this study were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments.

Funding

This study received no external funding.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Galarza-Delgado, D.A., Azpiri-Lopez, J.R., Colunga-Pedraza, I.J. et al. Prevalence of comorbidities in Mexican mestizo patients with rheumatoid arthritis. Rheumatol Int 37, 1507–1511 (2017). https://doi.org/10.1007/s00296-017-3769-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-017-3769-3

Keywords

Navigation